Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
14
2022
Philadelphia and Montana Join List of Jurisdictions That Provide Protections for Recreational Marijuana Use Hunton Andrews Kurth
Feb
14
2022
California COVID Supplemental Sick Leave is Back Foley & Lardner LLP
Feb
14
2022
USDA Reinstates School Nutrition Standards Keller and Heckman LLP
Feb
14
2022
FDA Opens Application Portal for Accreditation Bodies Under LAAF Program Keller and Heckman LLP
Feb
14
2022
Greenberg Traurig February 2022 Competition Currents: China and Japan Greenberg Traurig, LLP
Feb
14
2022
Top Trends in Tech-Enabled Home Care
Feb
11
2022
EUON Publishes Nanopinion on Why Graphene Is Not the Same as Carbon Nanotubes Bergeson & Campbell, P.C.
Feb
11
2022
Panel Rejects Status Quo Arguments and Upholds Injunction Finnegan
Feb
11
2022
Federal Cannabis Reform – Is 2022 the Year? Sheppard, Mullin, Richter & Hampton LLP
Feb
11
2022
Northern District of Illinois Dismisses BIPA Suit Against Canadian App Maker For Lack Of Personal Jurisdiction Squire Patton Boggs (US) LLP
Feb
11
2022
B.S. Beyond Stereotypes: BSing with Raqiyyah Pippins [PODCAST] Major Lindsey & Africa
Feb
10
2022
FDA Publishes Guidance on Chlorpyrifos Residues Keller and Heckman LLP
Feb
10
2022
China Food Packaging Year-In-Review: Looking Back on the Ox and Forward to the Tiger Keller and Heckman LLP
Feb
10
2022
Yes, A Secret Process Can (Still) Create an On-Sale Bar Squire Patton Boggs (US) LLP
Feb
9
2022
Mississippi Approves Medical Marijuana: What a Long, Strange Trip It’s Been Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Feb
9
2022
Illinois Supreme Court Eliminates Another BIPA Defense Vedder Price
Feb
9
2022
Proposed Class Sues Over “A Twist of Lemon” Claim Keller and Heckman LLP
Feb
8
2022
OECD Publishes Report on Important Issues on Risk Assessment of Manufactured Nanomaterials Bergeson & Campbell, P.C.
Feb
8
2022
US Federal Labor Viewpoints – Week of February 5, 2022 Squire Patton Boggs (US) LLP
Feb
8
2022
Registration Opens for SACC Meeting on Draft Screening Level Approach for Fenceline Communities; EPA Extends Comment Period Bergeson & Campbell, P.C.
Feb
8
2022
FDA Resumes Domestic Surveillance Inspections Keller and Heckman LLP
Feb
7
2022
Hydro Newsletter - Volume 9, Issue 2 Van Ness Feldman LLP
Feb
7
2022
Feeling Thirsty? Wall Street, Industry Giants Stir Renewed Interest in the CBD-Beverage Market Bradley Arant Boult Cummings LLP
Feb
7
2022
Prop 65 Settlement on Lead in Infant Formula Keller and Heckman LLP
Feb
7
2022
Use of Opioid Medications By Applicant For Forklift Job Was Not Sufficient to Deny Employment Without Individualized Assessment Jackson Lewis P.C.
Feb
5
2022
Retail Industry 2021 Year in Review: The EEOC & Artificial Intelligence: A Brief Primer for Retailers Hunton Andrews Kurth
Feb
4
2022
2022 Mental Health Parity Report to Congress Highlights Increased Enforcement Efforts Epstein Becker & Green, P.C.
Feb
4
2022
Opioid Update: Court Denies Pharmacies’ Motion for Certification of An Interlocutory Appeal Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins